Cargando…

Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus

Crimean-Congo Hemorrhagic Fever Virus (CCHFV) causes a life-threatening disease with up to a 40% mortality rate. With no approved medical countermeasures, CCHFV is considered a public health priority agent. The non-neutralizing mouse monoclonal antibody (mAb) 13G8 targets CCHFV glycoprotein GP38 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Durie, Ian A., Tehrani, Zahra R., Karaaslan, Elif, Sorvillo, Teresa E., McGuire, Jack, Golden, Joseph W., Welch, Stephen R., Kainulainen, Markus H., Harmon, Jessica R., Mousa, Jarrod J., Gonzalez, David, Enos, Suzanne, Koksal, Iftihar, Yilmaz, Gurdal, Karakoc, Hanife Nur, Hamidi, Sanaz, Albay, Cansu, Spengler, Jessica R., Spiropoulou, Christina F., Garrison, Aura R., Sajadi, Mohammad M., Bergeron, Éric, Pegan, Scott D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701186/ https://www.ncbi.nlm.nih.gov/pubmed/36435827 http://dx.doi.org/10.1038/s41467-022-34923-0

Ejemplares similares

Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
por: Scholte, F. E. M., et al.
Publicado: (2023)

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
por: Scholte, Florine E. M., et al.
Publicado: (2019)

The prognostic importance of platelet indices in patients with Crimean-Congo Hemorrhagic Fever
por: Aksoy, Firdevs, et al.
Publicado: (2017)

Evaluation of Serum TNF-alpha, IL-6, IL-10, and IFN-gamma Levels in Patients with Crimean–Congo Hemorrhagic Fever
por: Hülya, Yilmaz, et al.
Publicado: (2017)

Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus
por: Zivcec, Marko, et al.
Publicado: (2016)

Towards a Sustainable One Health Approach to Crimean–Congo Hemorrhagic Fever Prevention: Focus Areas and Gaps in Knowledge
por: Sorvillo, Teresa E., et al.
Publicado: (2020)

The Crimean-Congo Hemorrhagic Fever Virus NSm Protein Is Dispensable for Growth In Vitro and Disease in Ifnar(-/-) Mice
por: Welch, Stephen R., et al.
Publicado: (2020)

Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection
por: Scholte, Florine E. M., et al.
Publicado: (2019)

Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease
por: Garrison, Aura R., et al.
Publicado: (2019)

Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection
por: Spengler, Jessica R, et al.
Publicado: (2017)

Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar(-/-) mice
por: Welch, Stephen R., et al.
Publicado: (2019)

Crimean-Congo Hemorrhagic Fever in Turkey
por: Karti, S. Sami, et al.
Publicado: (2004)

Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles
por: Zivcec, Marko, et al.
Publicado: (2015)

Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals
por: Spengler, Jessica R., et al.
Publicado: (2016)

Host preferences support the prominent role of Hyalomma ticks in the ecology of Crimean-Congo hemorrhagic fever
por: Spengler, Jessica R., et al.
Publicado: (2018)

2310. No Recurrence in Recovered People with CCHF: A Cross-Sectional Study From Turkey, Preliminary Report
por: Koksal, Iftihar, et al.
Publicado: (2019)

Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
por: Welch, Stephen R., et al.
Publicado: (2023)

Post-ERCP bacteremia caused by Alcaligenes xylosoxidans in a patient with pancreas cancer
por: Yilmaz, Gurdal, et al.
Publicado: (2006)

Are New Biomarkers Useful in the Diagnosis of Meningitis in Adults?
por: Aksoy, Firdevs, et al.
Publicado: (2017)

Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response
por: Spengler, Jessica R., et al.
Publicado: (2019)

1541. A Novel and Fast Liquid Chromatography Method for Determination of Fluoroquinolones in Human Plasma
por: Yildirim, Sercan, et al.
Publicado: (2019)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
por: Kainulainen, Markus H., et al.
Publicado: (2023)

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice
por: Spengler, Jessica R., et al.
Publicado: (2018)

The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice
por: Golden, Joseph W., et al.
Publicado: (2022)

Viral RNA and infectious virus in mucosal specimens from guinea pigs modelling early phases of lethal and non-lethal Lassa fever
por: Welch, Stephen R., et al.
Publicado: (2022)

Optimal reference genes for RNA tissue analysis in small animal models of hemorrhagic fever viruses
por: Davies, Katherine A., et al.
Publicado: (2023)

Draft Genome Sequences of Eight Crimean-Congo Hemorrhagic Fever Virus Strains
por: Koehler, J. W., et al.
Publicado: (2017)

Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease
por: Welch, Stephen R., et al.
Publicado: (2022)

A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
por: Garrison, Aura R., et al.
Publicado: (2017)

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model
por: Gary, Joy M., et al.
Publicado: (2019)

Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses
por: Harmon, Jessica R., et al.
Publicado: (2020)

Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis
por: Smith, Darci R., et al.
Publicado: (2019)

Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin
por: Bergeron, Éric, et al.
Publicado: (2015)

2486. The Effectiveness of High-Dose Hepatitis B Vaccination in Patients Receiving Immunomodulatory Therapy
por: Aydin, Murat, et al.
Publicado: (2018)

Raoultella ornithinolytica causing fatal sepsis
por: Kaya, Selçuk, et al.
Publicado: (2015)

GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection
por: Golden, Joseph W., et al.
Publicado: (2019)

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model
por: Welch, Stephen R., et al.
Publicado: (2018)

Genome Sequences of Crimean-Congo Hemorrhagic Fever Virus Strains Isolated in South Africa, Namibia, and Turkey
por: Zivcec, Marko, et al.
Publicado: (2017)

The Crimean doctors: a history of the British Medical Services in the Crimean War
por: Summers, Anne
Publicado: (1992)

A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells
por: Hua, Brian L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3mdk3kcfqam418dp6f0d472e7